BPH Global Ltd (BP8) - Net Assets
Based on the latest financial reports, BPH Global Ltd (BP8) has net assets worth AU$-1.46 Million AUD (≈ $-1.04 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$541.00K ≈ $382.79K USD) and total liabilities (AU$2.01 Million ≈ $1.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of BPH Global Ltd to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-1.46 Million |
| % of Total Assets | -270.69% |
| Annual Growth Rate | N/A |
| 5-Year Change | -122.61% |
| 10-Year Change | -135.25% |
| Growth Volatility | 638.47 |
BPH Global Ltd - Net Assets Trend (1999–2025)
This chart illustrates how BPH Global Ltd's net assets have evolved over time, based on quarterly financial data. See BPH Global Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for BPH Global Ltd (1999–2025)
The table below shows the annual net assets of BPH Global Ltd from 1999 to 2025. For live valuation and market cap data, see market cap of BPH Global Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$-1.46 Million ≈ $-1.04 Million |
-14.93% |
| 2024-06-30 | AU$-1.27 Million ≈ $-901.59K |
-239.73% |
| 2023-06-30 | AU$911.90K ≈ $645.22K |
-80.68% |
| 2022-06-30 | AU$4.72 Million ≈ $3.34 Million |
-27.12% |
| 2021-06-30 | AU$6.48 Million ≈ $4.58 Million |
+752.18% |
| 2020-06-30 | AU$760.03K ≈ $537.77K |
-63.49% |
| 2019-06-30 | AU$2.08 Million ≈ $1.47 Million |
+73.36% |
| 2018-06-30 | AU$1.20 Million ≈ $849.55K |
-43.48% |
| 2017-06-30 | AU$2.12 Million ≈ $1.50 Million |
-48.87% |
| 2016-06-30 | AU$4.15 Million ≈ $2.94 Million |
+2672.57% |
| 2015-06-30 | AU$149.84K ≈ $106.02K |
+100.20% |
| 2014-06-30 | AU$-76.25 Million ≈ $-53.95 Million |
-212.18% |
| 2007-06-30 | AU$67.97 Million ≈ $48.09 Million |
+0.72% |
| 2006-06-30 | AU$67.48 Million ≈ $47.75 Million |
+10.35% |
| 2005-06-30 | AU$61.15 Million ≈ $43.27 Million |
+240.71% |
| 2004-06-30 | AU$17.95 Million ≈ $12.70 Million |
+42.04% |
| 2003-06-30 | AU$12.64 Million ≈ $8.94 Million |
+9.38% |
| 2002-06-30 | AU$11.55 Million ≈ $8.17 Million |
+2.33% |
| 2001-06-30 | AU$11.29 Million ≈ $7.99 Million |
+117.46% |
| 2000-06-30 | AU$5.19 Million ≈ $3.67 Million |
-7.73% |
| 1999-06-30 | AU$5.63 Million ≈ $3.98 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BPH Global Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6660768600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$80.20 Million | % |
| Other Comprehensive Income | AU$1.80 Million | % |
| Total Equity | AU$-1.45 Million | 100.00% |
BPH Global Ltd Competitors by Market Cap
The table below lists competitors of BPH Global Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Weaccess Group SA
PA:MLWEA
|
$3.33 Million |
|
DSJ Keep Learning Limited
NSE:KEEPLEARN
|
$3.33 Million |
|
PreveCeutical Medical Inc
F:18H
|
$3.34 Million |
|
Lightning Minerals Ltd
AU:L1M
|
$3.34 Million |
|
GRI Bio Inc.
NASDAQ:GRI
|
$3.33 Million |
|
Genesis Resources Ltd
AU:GES
|
$3.32 Million |
|
Millennium Silver Corp
V:MSC
|
$3.32 Million |
|
Pragma Inkaso S.A.
WAR:PRI
|
$3.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BPH Global Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -966,819 to -1,450,339, a change of -483,520.
- Net loss of 1,486,553 reduced equity.
- Other comprehensive income decreased equity by 118,361.
- Other factors increased equity by 1,121,394.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-1.49 Million | -102.5% |
| Other Comprehensive Income | AU$-118.36K | -8.16% |
| Other Changes | AU$1.12 Million | +77.32% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares BPH Global Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-06-30 | AU$28.70 | AU$0.00 | x |
| 2000-06-30 | AU$100.55 | AU$0.00 | x |
| 2001-06-30 | AU$37.47 | AU$0.00 | x |
| 2002-06-30 | AU$28.46 | AU$0.00 | x |
| 2003-06-30 | AU$27.61 | AU$0.00 | x |
| 2004-06-30 | AU$31.98 | AU$0.00 | x |
| 2005-06-30 | AU$16.08 | AU$0.00 | x |
| 2006-06-30 | AU$5.57 | AU$0.00 | x |
| 2007-06-30 | AU$15.13 | AU$0.00 | x |
| 2014-06-30 | AU$-40.83 | AU$0.00 | x |
| 2015-06-30 | AU$0.00 | AU$0.00 | x |
| 2016-06-30 | AU$0.01 | AU$0.00 | x |
| 2017-06-30 | AU$0.01 | AU$0.00 | x |
| 2018-06-30 | AU$0.00 | AU$0.00 | x |
| 2019-06-30 | AU$0.00 | AU$0.00 | x |
| 2020-06-30 | AU$0.00 | AU$0.00 | x |
| 2021-06-30 | AU$0.01 | AU$0.00 | x |
| 2022-06-30 | AU$0.00 | AU$0.00 | x |
| 2023-06-30 | AU$0.00 | AU$0.00 | x |
| 2024-06-30 | AU$0.00 | AU$0.00 | x |
| 2025-06-30 | AU$0.00 | AU$0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BPH Global Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -421.87%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (2354.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | -0.07% | 0.00% | 0.00x | 2.14x | AU$-566.78K |
| 2000 | 5.27% | 33.40% | 0.06x | 2.52x | AU$-245.63K |
| 2001 | -0.86% | -0.76% | 0.72x | 1.56x | AU$-1.23 Million |
| 2002 | 2.22% | 2.66% | 0.55x | 1.53x | AU$-899.19K |
| 2003 | 8.57% | 0.85% | 3.36x | 2.99x | AU$-180.18K |
| 2004 | 12.98% | 0.74% | 3.89x | 4.48x | AU$534.73K |
| 2005 | -10.63% | -0.48% | 3.46x | 6.43x | AU$-4.43 Million |
| 2006 | -151.45% | -1.83% | 3.74x | 22.18x | AU$-14.99 Million |
| 2007 | -11.28% | -0.28% | 3.61x | 11.12x | AU$-5.37 Million |
| 2015 | 50079.24% | 1098700.44% | 0.00x | 23.90x | AU$75.03 Million |
| 2016 | -857.33% | -47648.07% | 0.02x | 1.17x | AU$-36.03 Million |
| 2017 | -170.94% | -11483.85% | 0.01x | 1.24x | AU$-3.84 Million |
| 2018 | -279.29% | -1153.64% | 0.18x | 1.32x | AU$-3.47 Million |
| 2019 | -209.51% | -226.59% | 0.64x | 1.44x | AU$-3.71 Million |
| 2020 | -341.80% | -216.32% | 0.72x | 2.19x | AU$-1.63 Million |
| 2021 | -56.50% | -36.88% | 0.92x | 1.66x | AU$-3.69 Million |
| 2022 | -116.21% | -24.65% | 1.88x | 2.50x | AU$-3.84 Million |
| 2023 | -814.51% | -1273736.87% | 0.00x | 3.97x | AU$-4.37 Million |
| 2024 | 0.00% | -2065.73% | 0.16x | 0.00x | AU$-2.17 Million |
| 2025 | 0.00% | -421.87% | 0.65x | 0.00x | AU$-1.34 Million |
Industry Comparison
This section compares BPH Global Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $24,060,387
- Average return on equity (ROE) among peers: -56.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BPH Global Ltd (BP8) | AU$-1.46 Million | -0.07% | N/A | $3.33 Million |
| Althea Group Holdings Ltd (AGH) | $17.05 Million | -50.87% | 0.07x | $12.05 Million |
| BOD Science Ltd (BOD) | $4.81 Million | -100.25% | 0.85x | $3.01 Million |
| Cann Group Ltd (CAN) | $1.69 Million | -86.54% | 0.11x | $4.60 Million |
| ECS Botanics Holdings Ltd (ECS) | $3.81 Million | -91.97% | 2.37x | $4.52 Million |
| Ecofibre Ltd (EOF) | $40.97 Million | -108.24% | 0.74x | $5.36 Million |
| Epsilon Healthcare Ltd (EPN) | $25.32 Million | -43.24% | 0.47x | $6.06 Million |
| Elixinol Wellness Ltd (EXL) | $99.42 Million | 0.00% | 0.04x | $2.05 Million |
| IDT Australia Ltd (IDT) | $23.44 Million | -23.09% | 0.34x | $10.28 Million |
| Invion Ltd (IVX) | $40.00K | 0.00% | 35.08x | $2.61 Million |
About BPH Global Ltd
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more